What is the difference between Cortexin and Desmopressin?

Cortexin: Polypeptide bioregulator from bovine cortex; modulates neurotransmitter activity; activates GABA and dopamine systems; reduces excitotoxicity; stimulates neuronal repair Desmopressin: Synthetic vasopressin analogue (V2R selective); crosses blood-brain barrier; enhances hippocampal LTP and memory consolidation; longer-acting than natural vasopressin

Is Cortexin FDA approved?

Cortexin is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

Is Desmopressin FDA approved?

Desmopressin is FDA approved. This regulatory status is provided for research and educational context only.

How is Cortexin administered in research settings?

In research settings, Cortexin is typically administered via the intramuscular route. PeptideBase does not provide dosing or administration instructions.

How is Desmopressin administered in research settings?

In research settings, Desmopressin is typically administered via the intranasal, oral, or subcutaneous routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Cortexin vs Desmopressin

Peptide Comparison

Cortexin vs Desmopressin

Both are Neuro & Cognitive peptides.

Cortexin

Cortexin-10

CognitiveNot EvaluatedResearch Only

Half-life: Unknown

4 providers listed

Full Cortexin profile →

Desmopressin

DDAVP

CognitiveFDA ApprovedPrescription

Half-life: 1.5-2.5 hours (intranasal)

2 providers listed

Full Desmopressin profile →

Bottom line

Desmopressin is FDA-approved, while Cortexin is not evaluated — the clearest structural difference between them.

Quick Verdict

Cortexin

Half-life

Unknown

Desmopressin

Half-life

1.5-2.5 hours (intranasal)

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Desmopressin
Further along in FDA review	Desmopressin
Oral administration option	Desmopressin
More provider options (4 vs 2)	Cortexin

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Cortexin

Desmopressin

Mechanism Family

Neuro & Cognitive

Half-life

Unknown

1.5-2.5 hours (intranasal)

FDA Status

not evaluated

approved

Admin Routes

intramuscular

intranasal, oral, subcutaneous

Availability

Research Only

Prescription

Providers

4 listed

2 listed

Avail. Notes

Russian polypeptide preparation from cattle cerebral cortex. Registered in Russia for neurological conditions. No FDA approval, no NDA or IND, not on any FDA list. Research chemical in US.

FDA-approved synthetic vasopressin analog. Brands: DDAVP (NDA 017922), Stimate, Nocdurna (NDA 201532, Jun 2018). Approved forms: injection, intranasal, oral, sublingual. Prescription only.

Research Evidence

Cortexin

Review · 1 key study · dated evidence base — most recent 2013

Desmopressin

RCT · 5 key studies · most recent 2026

Research Citations

Cortexin

Review2013 · Advances in gerontology

Neuroprotective effects of peptides bioregulators in people of various age

Desmopressin

RCT1995 · Peptides

Failure of posttrial administration of vasopressin analogue (DDAVP) to influence memory in healthy, young, ma…

Cohort2026 · Clinical Endocrinology

Clinical Outcomes Following Supply-Driven Transition From Intranasal to Oral Desmopressin in AVP-Deficiency

Case series2026 · Cureus

Adult-Onset Multisystem Langerhans Cell Histiocytosis: Atypical Skeletal and Endocrine Manifestations.

Case series2026 · Cureus

Central Diabetes Insipidus Following Steroid Replacement for Hypoadrenalism in Pembrolizumab-Induced Hypophys…

+1 more

About Cortexin

Polypeptide bioregulator from bovine cortex; modulates neurotransmitter activity; activates GABA and dopamine systems; reduces excitotoxicity; stimulates neuronal repair

Research Areas

neuroprotection and neuronal survival supportcognitive function improvement — documented in Russian clinical settingsantioxidant activity in CNS tissueEEG normalization and neurotrophic factor expression

About Desmopressin

Synthetic vasopressin analogue (V2R selective); crosses blood-brain barrier; enhances hippocampal LTP and memory consolidation; longer-acting than natural vasopressin

Research Areas

memory consolidationlearning enhancementantidiuretichemostasis

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Cortexin

Reported (Unverified — Pending Clinical Review)

bovine protein allergy

No established clinical contraindications

Desmopressin

Reported (Unverified — Pending Clinical Review)

hyponatremiaheart failureuncontrolled hypertensionpsychogenic polydipsia

No established clinical contraindications

Suggested Monitoring

Under clinical review

Being verified by our medical team before we display monitoring guidance for this peptide.

Find Providers

Where to source these peptides

Providers offering

Cortexin

4 listed

Browse directory →

Providers offering

Desmopressin

2 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Neuro & Cognitive Comparisons

Browse all peptides →

Educational research tools — not medical advice.